Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: Review of 475 procedures

American Journal of Roentgenology

Volumn 199, Issue 3, 2012, Pages 691-694

  Barranco Pons, Roger ^a   Burrows, Patricia E ^b   Landrigan Ossar, Mary ^a   Trenor III, Cameron C ^a   Alomari, Ahmad I ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MEMORIAL HERMANN HOSPITAL   (United States)

Author keywords

Hemoglobinuria; Oliguria; Sclerotherapy; Venous malformation

Indexed keywords

ALCOHOL; DIURETIC AGENT; TETRADECYL SULFATE SODIUM;

ADULT; ALKALINIZATION; ARTERIOVENOUS MALFORMATION; ARTICLE; CHILD; CLINICAL EVALUATION; FEMALE; HEMOGLOBINURIA; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; OLIGURIA; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; REHYDRATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SCLEROTHERAPY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ETHANOL; FEMALE; HEMOGLOBINURIA; HUMANS; MALE; MIDDLE AGED; OLIGURIA; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SODIUM TETRADECYL SULFATE; VASCULAR MALFORMATIONS; VEINS; YOUNG ADULT;

EID: 84865606887     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.8285     Document Type: Article

References (15)

1. Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg 2000; 37:517-584
2. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999; 104:1-11
3. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 2004; 15:431-445 (Pubitemid 38590866)
4. Greene AK, Alomari AI. Management of venous malformations. Clin Plast Surg 2011; 38:83-93
5. Buchta K, Sands J, Rosenkrantz H, Roche WD. Early mechanism of action of arterially infused alcohol U.S.P. in renal devitalization. Radiology 1982; 145:45-48 (Pubitemid 13237618)
6. Duffy DM. Sclerosants: a comparative review. Dermatol Surg 2010; 36(suppl 2):1010-1025
7. Körmöczi GF, Säemann MD, Buchta C, et al. Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Invest 2006; 36:202-209 (Pubitemid 43341272)
8. Beutler E. Production and destruction of erythrocytes. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Williams hematology, 6th ed. New York, NY: McGraw-Hill, 2001:355-368
9. Kratz A, Lewandrowski KB. The plasma proteins. In: McClatchey KD, ed. Clinical laboratory medicine, 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2002:264-280
10. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293:1653-1662 (Pubitemid 40471796)
11. Hammer FD, Boon LM, Mathurin P, Vanwijck RR. Ethanol sclerotherapy of venous malformations: evaluation of systemic ethanol contamination. J Vasc Interv Radiol 2001; 12:595-600 (Pubitemid 32423070)
12. Gardner EC Jr, Brooks WS Jr. Absence of disseminated intravascular coagulation with endoscopic sclerosis of esophageal varices. Gastrointest Endosc 1982; 28:67-69
13. Wada H, Hashizume M, Yamaga H, Kitano S, Sugimachi K. Hemodynamic and morphological changes in the dog kidney after injection of 5% ethanolamine oleate into the superior vena cava. Eur Surg Res 1990; 22:63-70 (Pubitemid 20211663)
14. Miyoshi H, Ohshiba S, Matsumoto A, Takada K, Umegaki E, Hirata I. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate. Am J Gastroenterol 1991; 86:1638-1641
15. Ohta M, Hashizume M, Ueno K, Tanoue K, Sugimachi K. Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy. Hepatogastroenterology 1993; 40:65-68 (Pubitemid 23093928)